Russia - Life Sciences Lawyers & Law Firms - Europe - Chambers and Partners
Chambers & Partners has detected the use of an ad blocker.
We make use of tailor-made ads to enhance your experience of our website.
Please 'whitelist' https://www.chambersandpartners.com.
Close
Europe Guide

Life Sciences — Russia


Baker McKenzie - Life Sciences Department

-

Band 1

第一等

Chambers Commentary (based on the Chambers research)

What the team is known for Widely recognised as a leader in the life sciences market in Russia, the team maintains its stellar reputation. Advises major global pharmaceutical brands on regulatory matters, where the team is considered to offer in-depth expertise, as well as IP matters and commercial transactions. Additionally handles contentious cases. Also involved in cases relating to medical equipment. Regularly co-operates with associations of pharmaceutical companies.

Strengths Commentators particularly value the in-depth experience and responsiveness of the team. "Partners would take my call immediately or come back to me as soon as possible," a client says, adding: "They understand our business."

Sources recognise the team's long-established presence in the sector. "They have the biggest volume and the depth of experience," a source says, adding: "They created this practice from the beginning of the life sciences sector."

Work highlights Represented Laboratoires Servier in a trade mark dispute involving its attempt to invalidate KRKA's international registrations for the trade mark BRAVADIN as a result of its similarity with international non-proprietary name (INN) IVABRADIN.

Notable practitioners

Reputable head of department Paul Melling offers exceptional knowledge of Russian healthcare and pharmaceutical regulation. "He is very practical and has a lot of experience in Russia," a client reports, also praising his understanding of the local regulatory environment.

Alexey Trusov is an exceptional pharmaceutical and healthcare regulation specialist praised for his in-depth understanding of the industry. "He is a go-to person for commercial challenges; he also fully understands the regulatory and competition law sides," a client reports. Another source adds that "he is always able to explain."

Sergei Lomakin is an experienced associate advising clients on regulatory matters. "I can get answers even late at night. He always does everything on time even if questions are sent in at a very inconvenient time," a client reports.

About the Team (content provided by Baker McKenzie)

For more than 50 years Baker McKenzie has been effectively providing global advice in the pharmaceutical sector, and for over 25 of those years providing such advice here in Russia and the CIS. Having assisted in the foundation of the Association of International Pharmaceutical Manufacturers and the International Medical Devices Manufacturers Association, Baker McKenzie advises research based multinational pharmaceutical and medical device companies on a wide range of issues associated with their operations throughout Russia and the CIS, including:

  • Local manufacturing projects (joint ventures, contract manufacturing arrangements, acquisition transactions);
  • Commercial agreements, including distribution and joint marketing agreements;
  • Registration and circulation of medicines, medical equipment and products;
  • Industry policy, including special investment contracts;
  • Advertising and marketing regulations;
  • Competition law;
  • Patient support programs;
  • Regulation of clinical trials and clinical studies;
  • EAEU regulatory legislation;
  • Compliance work, including participation in internal investigations;
  • Import and export requirements;
  • Intellectual property, patent and trademark infringement (we were the first law firm to advise on a successful pharmaceutical patent infringement action before the Russian courts);
  • Pricing legislation, including innovative pricing;
  • Product liability;
  • Advising on the recovery of receivables from Russian distributors by way of litigation and insolvency proceedings.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Pepeliaev Group - Life Sciences Department

-

Band 1

第一等

Chambers Commentary (based on the Chambers research)

What the team is known for Climbs up to the top tier as a result of very positive market feedback and presence on significant cases. Advises on localisation and pricing issues as well as regulatory and compliance matters. Covers regulation of medical devices in addition to pharmaceutical products. Also handles antitrust and corporate matters for international pharmaceutical companies, and assists with investigations. Acts for importers, manufacturers and distributors.

Strengths Sources praise the team's service. "We really like them," a client says, further highlighting the team's "practical approach, clear advice, no problem with deadlines."

Interviewees laud the team's particular regulatory knowledge of the medical devices sector.

Work highlights Advised Abbott Laboratories on the launching of a new medical device in Russia.

Notable practitioners

Sergey Klimenko is a well-regarded specialist advising pharmaceutical clients on complex regulatory matters as well as commercial concerns. Clients benefit from his experience of working in-house for a pharmaceutical company. "He is very business-oriented but takes risks into account," a client says, adding that he provides "very balanced recommendations."

About the Team (content provided by Pepeliaev Group)

Pepeliaev Group team of 10 specialist lawyers is the biggest Life Sciences & Healthcare industry group at any law firm in Russia, boasting a considerable number of former in-house lawyers, while a further 19-25 lawyers from other departments are regularly involved in projects for these industries.

The lawyers of the practice have worked over many years with manufacturers, distributors, professional associations and regulators in medicine and pharmaceuticals, providing high-quality legal advice and helping companies to improve their performance and mitigate risks.

Our team is well known for its capability to handle the industry projects across the spectrum: from day-to-day advice on advertising products to multibillion dollar special investment contracts. The team is becoming increasingly popular for its unique experience in developing innovative public procurement models that increase the accessibility of expensive new-generation drugs to Russian patients. The practice is also renowned for its track record in clinical trials of medicinal products (extremely complicated legal cases, non-standard situations, etc.).

The practice offers legal services in such areas as:

  • ​the development of medicines, medical devices and BAA;
  • clinical research and trials;

  • localising manufacturing;

  • advising on registration issues;

  • wholesale and retail;

  • advertising and working with the professional comminity;

  • state control and supervision, interacting with consumers;

  • public procurement;

  • M&A.



No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Clifford Chance - Life Sciences Department

-

Band 2

第二等

Chambers Commentary (based on the Chambers research)

What the team is known for Widely reputed for its transactional and antitrust work for some of the largest international pharmaceutical and medical devices companies. Regularly instructed to handle localisation and anti-monopoly issues, including representing clients in antitrust litigation. Acts on regulatory matters.

Strengths Interviewees appreciate the team's assistance, with a client describing the lawyers as "very engaged, knowledgeable and responsive."

Work highlights Assisted Teva with the structuring and negotiating of a partnership with Nanolek to locally manufacture Teva's drug Copaxone.

Advised Pfizer on establishing commercial terms of its collaboration with NovaMedica.

Notable practitioners

Torsten Syrbe is a well-known competition law specialist with notable expertise in the life sciences sector, particularly in relation to antitrust matters. A source says that he is "very fast in responding," adding that he helps to decide "what risks can be taken by the business and what cannot."

About the Team (content provided by Clifford Chance)

We combine an outstanding legal and transactional track record with an in-depth understanding of the industry. We are able to identify and advise our clients on key risks from an operational and a legal/regulatory perspective

M&A Transactions

We have a strong track record advising clients on joint ventures and M&A transactions in the pharmaceuticals sector, including the acquisition of production facilities. Many of these transactions have involved due diligence review of pharmaceuticals businesses in Russia, including their contractual structures and title to real estate.

Day-to-day Business Advice for Pharmaceutical and Medical Devices Companies

We regularly advise our clients on their day-to-day business issues in the pharmaceuticals and medical devices sector, including market access (mainly licensing and product registration requirements), distribution structures, commercial contracts, price regulation, marketing and advertising issues.

Highly-rated Antitrust Team

Our long-standing dedicated antitrust practice focuses on the Russian healthcare sector. We have an outstanding reputation advising clients on merger control and foreign investment issues that arise in M&A
transactions.

Anti-corruption, FCPA Compliance and International Sanctions

Our team regularly advises international clients on compliance aspects in the Russian pharmaceuticals sector, participation in state auctions and tenders, public procurement rules, international compliance and sanctions issues.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


CMS - Life Sciences Department

-

Band 3

第三等

Chambers Commentary (based on the Chambers research)

What the team is known for Active in non-contentious matters, including regulatory and licensing issues, commercial distribution, IP and corporate work. Also advises clients on clinical trials, pricing and competition law matters. Often instructed on cross-border deals, assisting both local and global medical devices and pharmaceutical companies.

Strengths Sources recognise the team's visibility in the sector, with a peer saying: "We see them and they are obviously well regarded for their healthcare practice."

Work highlights Assisted Roche Diabetes Care with the localisation of the production of test strips for glucose meters in Russia.

Advised Johnson & Johnson on the regulatory matters related to the distribution of medical devices in the Russian market.

Notable practitioners

Department head Vsevolod Tyupa is a well-regarded lawyer advising both domestic and international clientele on localisation of healthcare businesses as well as distribution, clinical trials and regulatory compliance. "He tries to find the most convenient option for me as a client," an interviewee reports.

About the Team (content provided by CMS)

Department profile not yet provided by CMS. Please see their firm profile.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Dentons - Life Sciences Department

-

Band 3

第三等

Chambers Commentary (based on the Chambers research)

What the team is known for Offers a broad spectrum of services to pharmaceutical and medical devices companies, advising on compliance, regulatory and IP matters. Advises on commercial concerns such as manufacturing and distribution agreements. Also assists with related transactional and real estate instructions.

Strengths Sources highlight the team's practical approach, with a client saying that "they are pragmatic, they know how things work in practice."

Notable practitioners

Alexander Skoblo is a key contact for clients.

About the Team (content provided by Dentons)

Department profile not yet provided by Dentons. Please see their firm profile.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Hogan Lovells (CIS) - Life Sciences Department

-

Band 3

第三等

Chambers Commentary (based on the Chambers research)

What the team is known for Particularly noted for its experience of IP matters in life sciences sector. Notable track record in handling contentious trade mark and patent cases, including in cross-border matters. Also assists with regulatory issues.

Strengths Sources note the team's dedication. A client highlights "a very innovative approach in strategy planning," adding: "Everything is on time, very effective and we could speak till midnight before disputes."

Work highlights Represented GlaxoSmithKline and ViiV Healthcare in disputes relating to the alleged patent infringement of lamivudine and abacavir by generic companies in Russia, Ukraine and Kazakhstan.

Represented Bayer in the proceedings against a Russian producer before the Russian antitrust authority claiming trade dress infringement.

Notable practitioners

Natalia Gulyaeva is a well-regarded IP lawyer with significant experience in assisting life sciences companies. Sources highlight her responsiveness and in-depth knowledge of IP topics.

About the Team (content provided by Hogan Lovells (CIS))

Department profile not yet provided by Hogan Lovells (CIS). Please see their firm profile.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Lidings - Life Sciences Department

-

Band 3

第三等

Chambers Commentary (based on the Chambers research)

What the team is known for Noted for strength in regulatory matters pertaining to the pharmaceutical sector. Represents major international pharmaceutical companies and regional mid-sized companies in compliance issues, market entry and patent infringement as well as antitrust matters. Also assists with localisation and advertising-related matters.

Strengths Sources praise the team's responsiveness, with a client saying that "everything is on time," adding that the lawyers are "always available."

Work highlights Advised Valenta Pharm on the transfer of a drug registration certificate and related IP assets to another company.

Notable practitioners

Andrey Zelenin is an experienced corporate lawyer with significant experience in handling regulatory pharma issues. "He is very to the point," a client says.

About the Team (content provided by Lidings)

Department profile not yet provided by Lidings. Please see their firm profile.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Vegas Lex - Life Sciences Department

-

Band 3

第三等

Chambers Commentary (based on the Chambers research)

What the team is known for Assists predominantly domestic pharmaceutical companies with compliance, advertising and commercial matters and also acts for a number of multinationals. Has practical experience in relation to state procurement tenders, pharmaceuticals import regulations and IP rights relating to pharmaceutical products.

Work highlights Advised InPharma on a number of regulatory changes, including pricing and government tender rules.

Notable practitioners

Alexander Sitnikov is a key contact for clients.

About the Team (content provided by Vegas Lex)

Department profile not yet provided by Vegas Lex. Please see their firm profile.

No Content Provided

Industries

  • {{member.name}}

No Content Provided

Clients

  • {{member.name}}

No Content Provided

Date

Title

{{ article.publishedDate | date: 'longDate' }}

{{article.title}}


Band 1

Baker McKenzie

From the Chambers Europe guide

Reputable head of department Paul Melling offers exceptional knowledge of Russian healthcare and pharmaceutical regulation. "He is very practical and has a lot of experience in Russia," a client reports, also praising his understanding of the local regulatory environment.

^ See whole ranking table

Band 1

Baker McKenzie

From the Chambers Europe guide

Alexey Trusov is an exceptional pharmaceutical and healthcare regulation specialist praised for his in-depth understanding of the industry. "He is a go-to person for commercial challenges; he also fully understands the regulatory and competition law sides," a client reports. Another source adds that "he is always able to explain."

^ See whole ranking table

Band 2

TRUBOR law firm

From the Chambers Europe guide

Maria Borzova joined TRUBOR law firm from Vegas Lex in December 2017. She is a notable regulatory expert in the healthcare and pharmaceutical industries. "She works very well under pressure," a client says. Another source adds: "She is able to explain boring stuff in a quite exciting way, she has good presentation skills."

^ See whole ranking table

Band 2

Pepeliaev Group

From the Chambers Europe guide

Sergey Klimenko is a well-regarded specialist advising pharmaceutical clients on complex regulatory matters as well as commercial concerns. Clients benefit from his experience of working in-house for a pharmaceutical company. "He is very business-oriented but takes risks into account," a client says, adding that he provides "very balanced recommendations."

^ See whole ranking table

Band 2

CMS

From the Chambers Europe guide

Department head Vsevolod Tyupa is a well-regarded lawyer advising both domestic and international clientele on localisation of healthcare businesses as well as distribution, clinical trials and regulatory compliance. "He tries to find the most convenient option for me as a client," an interviewee reports.

^ See whole ranking table

Band 3

Hogan Lovells (CIS)

From the Chambers Europe guide

Natalia Gulyaeva is a well-regarded IP lawyer with significant experience in assisting life sciences companies. Sources highlight her responsiveness and in-depth knowledge of IP topics.

^ See whole ranking table

Band 3

Baker McKenzie

From the Chambers Europe guide

Sergei Lomakin is an experienced associate advising clients on regulatory matters. "I can get answers even late at night. He always does everything on time even if questions are sent in at a very inconvenient time," a client reports.

^ See whole ranking table

Band 3

Clifford Chance

From the Chambers Europe guide

Torsten Syrbe is a well-known competition law specialist with notable expertise in the life sciences sector, particularly in relation to antitrust matters. A source says that he is "very fast in responding," adding that he helps to decide "what risks can be taken by the business and what cannot."

^ See whole ranking table

Band 3

Vladislav Ugryumov

Gowling WLG

From the Chambers Europe guide

Vladislav Ugryumov of Gowling WLG is highly praised for his exceptional expertise in patent litigation and prosecution and also assists with regulatory issues.

^ See whole ranking table

Band 3

Lidings

From the Chambers Europe guide

Andrey Zelenin is an experienced corporate lawyer with significant experience in handling regulatory pharma issues. "He is very to the point," a client says.

^ See whole ranking table